FDA label c61bac4c-d8e3-4709-ac11-213f626a88bf
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- SPL set ID
- 156263bd-5a6f-47e4-afe4-c952f1044072
- SPL ID
- c61bac4c-d8e3-4709-ac11-213f626a88bf
- Version
- 1
- Effective date
- 2010-09-08
- Source export date
- 2026-10-12
- Source partition
- 7
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-10-12/ff22b88bd32e56cbc369af80345075227138a42b1b3ba9a84f038fd5493a7a47/drug-label-0007-of-0014.json.zip
- Source manifest SHA-256
- 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
- Import run
- 20261013T011858Z
- Imported at
- 2026-10-13 02:04:52
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| spl id | c61bac4c-d8e3-4709-ac11-213f626a88bf | id | |
| spl set id | 156263bd-5a6f-47e4-afe4-c952f1044072 | set_id |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
WARNINGS:DO NOT ADMINISTER BALANCED SALT SOLUTIONS INTRAVENOUSLY. NOT FOR INJECTION.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS: Bullous keratopathy may result when abnormal corneal endothelium is irrigated or subjected to any other trauma. There have been reports of corneal clouding and corneal edema following ocular surgery in which a balanced salt solution was used for irrigation. The frequency of such events has not been established adequately. Should any adverse reaction occur, discontinue use of this product, institute appropriate care, and save the remaining fluid for analysis.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.